AdventHealth Launches NIH-Funded THRIVE Trial to Address Apathy in Late-Life Depression

AdventHealth Neuroscience Institute is launching THRIVE, a new NIH-funded clinical trial led by geriatric neuropsychologist and neuroscience researcher Lauren Oberlin, PhD. The study will test whether digital cognitive training — a series of computer-based brain exercises — can improve mood, cognitive function, and brain network connectivity in older adults experiencing apathy and depression.

Apathy, a motivational disturbance that impacts up to 50% of people with late-life depression, often leads to social withdrawal, poor self-care, and increased disability. Current treatments like antidepressants may not address apathy and, in some cases, can worsen it. THRIVE aims to fill this gap with a non-invasive, home-based intervention that involves 25–30 minutes of engaging brain training five days a week for four weeks.

Participants will complete mood and cognitive assessments, as well as brain imaging, to help researchers understand how digital training may re-engage critical brain networks. “We are excited about this trial as it has the potential to identify a novel intervention that can be used alongside current treatments to improve outcomes for older adults,” says Dr. Oberlin.

Learn more about this study by clicking below.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Advancing T1D Science: New TRI Publications

Researchers at the AdventHealth Translational Research Institute continue to drive meaningful progress in Type 1 diabetes—work that is being recognized not just in Central Florida, but throughout the...